These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


275 related items for PubMed ID: 1531500

  • 1. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies.
    O'Doherty MJ, Kettle AG, Wells P, Collins RE, Coakley AJ.
    J Nucl Med; 1992 Mar; 33(3):313-8. PubMed ID: 1531500
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
    Taillefer R, Boucher Y, Potvin C, Lambert R.
    J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
    Billy HT, Rimkus DR, Hartzman S, Latimer RG.
    Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
    Apostolopoulos DJ, Houstoulaki E, Giannakenas C, Alexandrides T, Spiliotis J, Nikiforidis G, Vlachojannis JG, Vassilakos PJ.
    J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
    [Abstract] [Full Text] [Related]

  • 8. In vivo uptake of technetium-99M-sestamibi by parathyroid glands in comparison to surrounding tissues of the neck.
    Waters GS, Burke GJ, Corley JH, Wei JP.
    Am Surg; 1997 Feb; 63(2):195-8. PubMed ID: 9012436
    [Abstract] [Full Text] [Related]

  • 9. 99Tcm sestamibi--a new agent for parathyroid imaging.
    Coakley AJ, Kettle AG, Wells CP, O'Doherty MJ, Collins RE.
    Nucl Med Commun; 1989 Nov; 10(11):791-4. PubMed ID: 2532313
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC, Holder LE, Scovill WA, Tehan AM, Gann DS.
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [Abstract] [Full Text] [Related]

  • 14. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging.
    Johnston LB, Carroll MJ, Britton KE, Lowe DG, Shand W, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):346-52. PubMed ID: 8550776
    [Abstract] [Full Text] [Related]

  • 15. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Fröberg AC, Valkema R, Bonjer HJ, Krenning EP.
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
    [Abstract] [Full Text] [Related]

  • 16. Preliminary results of thallium 201 and technetium 99m subtraction scanning of parathyroid glands.
    Wheeler MH, Harrison BJ, French AP, Leach KG.
    Surgery; 1984 Dec; 96(6):1078-82. PubMed ID: 6095480
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 123I-methylene blue: an unsatisfactory parathyroid imaging agent.
    Blower PJ, Kettle AG, O'Doherty MJ, Collins RE, Coakley AJ.
    Nucl Med Commun; 1992 Jul; 13(7):522-7. PubMed ID: 1386657
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.